Eli Lilly and Co
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 43K
- Market Cap
- $859.4B
- Introduction
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis
- Conditions
- Atopic Dermatitis
- Interventions
- Drug: LY3375880Drug: Placebo
- First Posted Date
- 2019-02-05
- Last Posted Date
- 2021-04-20
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 136
- Registration Number
- NCT03831191
- Locations
- 🇨🇿
Sanatorium Profesora Arenbergera, Praha 1, Czechia
🇨🇿Clintrial, s.r.o., Praha 10, Hl. M. Praha, Czechia
🇫🇷CHU de Nice Hopital de L'Archet, Nice cedex 3, France
A Safety Study of LY3372689 Given By Mouth to Healthy Participants
- Conditions
- Healthy
- Interventions
- Drug: LY3372689Drug: Placebo
- First Posted Date
- 2019-01-28
- Last Posted Date
- 2019-07-05
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 23
- Registration Number
- NCT03819270
- Locations
- 🇺🇸
Covance, Dallas, Texas, United States
An Interaction Study of LY3200882 in Healthy Participants
- First Posted Date
- 2019-01-03
- Last Posted Date
- 2019-03-08
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 23
- Registration Number
- NCT03792139
- Locations
- 🇺🇸
Covance Clinical Research Inc, Daytona Beach, Florida, United States
A Study of Baricitinib in Participants From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
- First Posted Date
- 2018-12-12
- Last Posted Date
- 2022-10-07
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 220
- Registration Number
- NCT03773978
- Locations
- 🇨🇳
Children's Hospital of Soochow University, Suzhou, China
🇦🇺Royal Childrens Hospital Melbourne, Parkville, Victoria, Australia
🇦🇷Centro Medico Privado de Reumatologia, SAN M. DE Tucuman, Tucumán, Argentina
A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
- First Posted Date
- 2018-12-12
- Last Posted Date
- 2024-12-03
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 190
- Registration Number
- NCT03773965
- Locations
- 🇧🇷
Hospital de Clinicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil
🇨🇳Beijing Peking Union Medical College Hospital, Beijing, Beijing, China
🇯🇵Institute of Science Tokyo Hospital, Bunkyō, Tokyo, Japan
A Study of LY3405105 in Participants With Advanced Cancer
- Conditions
- Solid Tumor
- Interventions
- Drug: LY3405105
- First Posted Date
- 2018-12-10
- Last Posted Date
- 2021-11-08
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 54
- Registration Number
- NCT03770494
- Locations
- 🇪🇸
Hospital Madrid Norte Sanchinarro, Madrid, Spain
🇫🇷Gustave Roussy, Villejuif Cedex, France
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
A Study Comparing User Experience of Different Delivery Devices for Glucagon
- Conditions
- Healthy
- Interventions
- Device: Nasal Glucagon Device (NG)Device: GEKDrug: IM Glucagon
- First Posted Date
- 2018-12-05
- Last Posted Date
- 2020-03-20
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 99
- Registration Number
- NCT03765502
- Locations
- 🇺🇸
High Point Clinical Trials Center, High Point, North Carolina, United States
A Study of LY3463251 in Healthy Participants
- Conditions
- Healthy
- Interventions
- Drug: PlaceboDrug: LY3463251
- First Posted Date
- 2018-12-05
- Last Posted Date
- 2020-12-21
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 118
- Registration Number
- NCT03764774
- Locations
- 🇺🇸
Covance Clinical Research Inc, Daytona Beach, Florida, United States
Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer
- Conditions
- Metastatic Breast Cancer
- First Posted Date
- 2018-12-04
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Eli Lilly and Company
- Registration Number
- NCT03763604
- Locations
- 🇦🇺
Liverpool Hospital, Liverpool, New South Wales, Australia
🇦🇺North West Cancer Centre, North Tamworth, New South Wales, Australia
🇦🇺St Vincent's Hospital Sydney, Sydney, New South Wales, Australia
A Study of LY900014 in a Medtronic Pump
- First Posted Date
- 2018-11-30
- Last Posted Date
- 2020-10-29
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 42
- Registration Number
- NCT03760640
- Locations
- 🇺🇸
Atlanta Diabetes Associates, Atlanta, Georgia, United States
🇺🇸International Diabetes Center, Saint Louis Park, Minnesota, United States